1,2,3-Trichloropropane

CASRN 96-18-4

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (33 pp, 283 K) last updated: 09/30/2009

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
4 x10-3 Hepatic Increased absolute liver weight in male rats BMDL (ADJ): 1.1
mg/kg-day
300 Medium/High

Reference Concentration for Inhalation Exposure (RfC) (PDF) (33 pp, 283 K) last updated: 09/30/2009

RfC (mg/m3) System Basis PoD Composite UF Confidence
3 x10-4 Respiratory peribronchial lymphoid hyperplasia in male rats BMCL (HEC): 0.90
mg/m3
3000 Low

Cancer Assessment


Weight of Evidence for Cancer (PDF) (33 pp, 283 K) last updated: 09/30/2009

WOE Characterization Framework for WOE Characterization
Likely to be carcinogenic to humans Guidelines for Carcinogen Risk Assessment (US EPA, 2005)
Basis:
  • Under the Guidelines for Carcinogenic Risk Assessment (U.S. EPA, 2005a), 1,2,3-trichloropropane is "likely to be carcinogenic to humans", based on a statistically significant and dose-related increase in the formation of multiple tumors in both sexes of two species from an NTP (1993) chronic oral bioassay.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (33 pp, 283 K)

Oral Slope Factor: 3 x10 1 per mg/kg-day
Extrapolation Method: Multistage-Weibull model with linear extrapolation from the point of departure (BMDL10).
Tumor site(s): Reproductive, Ocular, Hepatic, Gastrointestinal
Tumor type(s): alimentary system squamous cell neoplasms, liver hepatocellular adenomas or carcinomas, Harderian gland adenomas, uterine/cervix adenomas or carcinomas (NTP (1993))


Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (33 pp, 283 K)

Not Assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.